Abbonarsi

Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis - 11/12/20

Doi : 10.1016/j.ajem.2020.09.018 
Baris Gungor, M.D. a, Adem Atici, M.D. b, Omer Faruk Baycan, M.D. b, Gokhan Alici, M.D. c, Fatih Ozturk, M.D. d, Sevil Tugrul, M.D. e, Ramazan Asoglu, M.D. f, Erdem Cevik, M.D. g, Irfan Sahin, M.D. e, Hasan Ali Barman, M.D. h,
a University of Health Sciences, Dr. Siyami Ersek Training and Research Hospital, Department of Cardiology, Istanbul, Turkey 
b Istanbul Medeniyet University, Faculty of Medicine, Goztepe Training and Research Hospital, Department of Cardiology, Istanbul, Turkey 
c University of Health Sciences, Okmeydani Training and Research Hospital, Department of Cardiology, Istanbul, Turkey 
d Yuzunci Yil University, Faculty of Medicine, Department of Cardiology, Van, Turkey 
e University of Health Sciences, Bagcilar Training and Research Hospital, Department of Cardiology, Istanbul, Turkey 
f University of Health Sciences, Adiyaman Training and Research Hospital, Department of Cardiology, Adiyaman, Turkey 
g Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology, Istanbul, Turkey 
h Istanbul University – Cerrahpasa, Institute of Cardiology, Department of Cardiology, Istanbul, Turkey 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

In this systematic review and meta-analysis, we aimed to investigate the correlation of D-dimer levels measured on admission with disease severity and the risk of death in patients with coronavirus disease 2019 (COVID-19) pneumonia.

Materials and methods

We performed a comprehensive literature search from several databases. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed in abstracting data and assessing validity. Quality assessment was performed using the Newcastle-Ottawa quality assessment scale (NOS). D-dimer levels were pooled and compared between severe/non-severe and surviving/non-surviving patient groups. Weighted mean difference (WMD), risk ratios (RRs) and 95% confidence intervals (CIs) were analyzed.

Results

Thirty-nine studies reported on D-dimer levels in 5750 non-severe and 2063 severe patients and 16 studies reported on D-dimer levels in 2783 surviving and 697 non-surviving cases. D-dimer levels were significantly higher in patients with severe clinical status (WMD: 0.45 mg/L, 95% CI: 0.34–0.56; p < 0.0001). Non-surviving patients had significantly higher D-dimer levels compared to surviving patients (WMD: 5.32 mg/L, 95% CI: 3.90–6.73; p < 0.0001). D-dimer levels above the upper limit of normal (ULN) was associated with higher risk of severity (RR: 1.58, 95% CI: 1.25–2.00; p < 0.0001) and mortality (RR: 1.82, 95% CI: 1.40–2.37; p < 0.0001).

Conclusion

Increased levels of D-dimer levels measured on admission are significantly correlated with the severity of COVID-19 pneumonia and may predict mortality in hospitalized patients.

Il testo completo di questo articolo è disponibile in PDF.

Highlights

The novel Coronavirus has caused a global outbreak of respiratory illness.
Thrombotic complications and coagulopathies have become a major cause of morbidity and mortality.
D-dimer is the degradation product of fibrin and reflects activation of coagulation and fibrinolysis.
Elevated d-dimer levels are strongly associated with disease severity and increased mortality.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2020  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 39

P. 173-179 - gennaio 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • After a century, Epinephrine's role in cardiac arrest resuscitation remains controversial
  • Kasha Bornstein, Brit Long, Alessandra Della Porta, Guy Weinberg
| Articolo seguente Articolo seguente
  • Diagnostic modalities to determine ventriculoperitoneal shunt malfunction: A systematic review and meta-analysis
  • Aditi Jayanth, Roshanak Benabbas, Jennifer Chao, Richard Sinert

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.